Capital Rx is a health technology company changing the way prescription drugs are priced and patients are serviced.
Capital Rx is on a mission to change the way prescriptions are priced and administered to create enduring social change.
Capital Rx was founded in 2017 by Anthony J. Loiacono. The company is headquartered in New York, New York.
Capital Rx has built an enterprise pharmacy platform JUDI™, which connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement and increasing efficiency to achieve the highest standards of clinical care.
JUDI™ is built to be the future infrastructure of healthcare, driving administrative cost down while improving the patient experience. In addition, as a cloud-based, serverless platform built on an open API architecture, JUDI™ delivers unlimited scale and ease of integration.
Capital Rx serves all members and all products, including commercial, Medicare, and Medicaid lines of business. The platform is on track to add over 1 million new lives for the 2023 plan year.
Capital Rx is backed by B Capital, General Catalyst, Edison Partners, Transformation Capital, Paycheck Protection Program, and others. The company raised $106M in Series C round on Jun 13, 2022. This brings Capital Rx's total funding to $207M to date.